[Diffuse lung diseases and biological markers in serum].
Takahashi
Hiroki
H
Shiratori
Masanori
M
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm / Q000097:blood*; D015415:Biomarkers / Q000097:blood*; D003095:Collagen Diseases / Q000150:complications; D000077156:Gefitinib; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000175:diagnosis* / Q000209:etiology; D018396:Mucin-1; D009077:Mucins / Q000097:blood*; D037662:Pulmonary Surfactant-Associated Protein A / Q000097:blood*; D037663:Pulmonary Surfactant-Associated Protein D / Q000097:blood*; D011799:Quinazolines / Q000009:adverse effects; D017564:Radiation Pneumonitis / Q000175:diagnosis; D011933:Reagent Kits, Diagnostic; D012128:Respiratory Distress Syndrome / Q000175:diagnosis*; D012680:Sensitivity and Specificity
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D015415:Biomarkers; C060192:MUC1 protein, human; D018396:Mucin-1; D009077:Mucins; D037662:Pulmonary Surfactant-Associated Protein A; D037663:Pulmonary Surfactant-Associated Protein D; D011799:Quinazolines; D011933:Reagent Kits, Diagnostic; D000077156:Gefitinib